Anzeige
Mehr »
Login
Montag, 31.03.2025 Börsentäglich über 12.000 News von 695 internationalen Medien

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A1JTC2 | ISIN: FR0011184241 | Ticker-Symbol: A89
Tradegate
26.03.25
14:59 Uhr
4,000 Euro
+0,200
+5,26 %
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
ADOCIA SAS Chart 1 Jahr
5-Tage-Chart
ADOCIA SAS 5-Tage-Chart
RealtimeGeldBriefZeit
3,9253,97520:04
3,9403,97519:09

Aktuelle News zur ADOCIA Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
14.03.Number of Shares and Voting Rights of ADOCIA as of February 28th, 2025215Regulatory News: Pursuant to the provisions of article L. 233-8 II of the French "Code de Commerce" and article 223-16 of the General Regulation of the French stock-market authorities (Autorité...
► Artikel lesen
28.02.ADOCIA Announces the Settlement-Delivery of its €9.7 Million Private Placement662Regulatory News: NOT FOR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES OF AMERICA, CANADA, AUSTRALIA, JAPAN AND SOUTH AFRICA Adocia (Euronext Paris: FR0011184241 ADOC), a clinical-stage...
► Artikel lesen
26.02.Adocia raises €9.7 million in private placement, extending cash runway to Q2 20261
ADOCIA Aktie jetzt für 0€ handeln
26.02.ADOCIA Announces the Successful Completion of a €9.7 Million Private Placement, Extending its Cash Runway to Q2 2026527Capital increase of a total amount of €9.7 million in gross proceeds by issuing a total number of 2,125,000 new shares, each with one share warrant attached, at €4.58 per share Gross Proceeds...
► Artikel lesen
25.02.ADOCIA Reports Fourth Quarter 2024 Financial Results and Provides a Business Update284Cash position of €7.5 million as of December 31, 2024 BioChaperone Lispro final dosing of Phase 3 triggered a $10 million revenue recognition, and top-line data are expected in mid-2025...
► Artikel lesen
14.02.Number of Shares and Voting Rights of ADOCIA as of January 31st, 2025244Regulatory News: Pursuant to the provisions of article L. 233-8 II of the French Code de Commerce and article 223-16 of the French stock-market authorities (Autorité des Marchés Financiers, or...
► Artikel lesen
22.01.ADOCIA Announces Half-Year Report on Adocia's Liquidity Agreement with Kepler Capital Markets347Regulatory News: Under the liquidity agreement entrusted by Adocia (Euronext Paris: FR0011184241 ADOC) to Kepler Capital Markets, the following resources were listed on the liquidity account on...
► Artikel lesen
17.01.Number of Shares and Voting Rights of ADOCIA as of December 31st, 2024338Regulatory News: Pursuant to the provisions of article L. 233-8 II of the French Code de Commerce and article 223-16 of the French stock-market authorities (Autorité des Marchés Financiers, or...
► Artikel lesen
23.12.24ADOCIA Announces Its Participation at Upcoming Investor Conferences in 2025348Regulatory News: Adocia (Euronext Paris: FR0011184241 ADOC, the "Company"), a clinical-stage biopharmaceutical company focused on the research and development of innovative therapeutic solutions...
► Artikel lesen
19.12.24ADOCIA Announces its Financial Calendar for 2025339Regulatory News: Adocia (Euronext Paris: FR0011184241 ADOC), a clinical-stage biopharmaceutical company focused on the research and development of innovative therapeutic solutions for the treatment...
► Artikel lesen
12.12.24ADOCIA and Tonghua Dongbao Announce the Final Dosing in a Phase 3 Clinical Study of BioChaperone Lispro, Milestone Associated with a $10 Million Payment471Final dosing of the last patient concludes the Phase 3 study in people with Type 2 diabetes, event associated with a $10 million payment from Tonghua Dongbao to Adocia Phase 3 topline results...
► Artikel lesen
04.12.24ADOCIA SA: Number of Shares and Voting Rights of ADOCIA as of November 30th, 2024281Regulatory News: Pursuant to the provisions of article L. 233-8 II of the French Code de Commerce and article 223-16 of the French stock-market authorities (Autorité des Marchés Financiers, or...
► Artikel lesen
08.11.24ADOCIA SA: Number of Shares and Voting Rights of ADOCIA as of October 31st, 2024415Regulatory News: Pursuant to the provisions of article L. 233-8 II of the French Code de Commerce and article 223-16 of the French stock-market authorities (Autorité des Marchés Financiers, or...
► Artikel lesen
30.10.24ADOCIA Reports Third Quarter 2024 Financial Results and Provides a Business Update419Cash position of €9.3 million as of September 30, 2024 Completion of the Phase 3 study on BioChaperone Lispro expected in December 2024, associated with a $10 million payment by Tonghua...
► Artikel lesen
15.10.24ADOCIA Announces Patenting Stable Combinations of GLP-1 and Amylin Analogs for the Treatment of Obesity and Diabetes Using Its BioChaperone Platform327Adocia has filed patent applications of stable combinations of semaglutide in combination with cagrilintide BioChaperone CagriSema could be administered with all standard subcutaneous injection...
► Artikel lesen
08.10.24Number of Shares and Voting Rights of ADOCIA as of September 30th, 2024448Regulatory News: Pursuant to the provisions of article L. 233-8 II of the French Code de Commerce and article 223-16 of the French stock-market authorities (Autorité des Marchés Financiers, or...
► Artikel lesen
23.09.24ADOCIA Announces Appointment of Mathieu-William Gilbert as Chief Financial Officer578Valérie Danaguezian, who has held the position of Chief Financial Officer since Adocia's founding in 2005, is leaving the company to focus on a family project Mathieu-William Gilbert will...
► Artikel lesen
20.09.24Number of Shares and Voting Rights of ADOCIA as of August 31st, 2024353Regulatory News: Pursuant to the provisions of article L. 233-8 II of the French Code de Commerce and article 223-16 of the French stock-market authorities (Autorité des Marchés Financiers, or...
► Artikel lesen
19.09.24ADOCIA Announces First Half 2024 Financial Results and Provides a Business Update1.001Cash position of €10.3 million as of June 30, 2024 Net loss of €8.9 million as of June 30, 2024, comparable to the same period in 2023 Debt limited to a state-guaranteed loan amounting...
► Artikel lesen
30.08.24Number of Shares and Voting Rights of ADOCIA as of July 31st, 2024271Regulatory News: Pursuant to the provisions of article L. 233-8 II of the French Code de Commerce and article 223-16 of the French stock-market authorities (Autorité des Marchés Financiers, or...
► Artikel lesen
Seite:  Weiter >>
35 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1